Europe Erectile Dysfunction Drugs Market Size & Outlook
Europe erectile dysfunction drugs market, 2018-2030 (US$M)
Related Markets
Europe erectile dysfunction drugs market highlights
- The Europe erectile dysfunction drugs market generated a revenue of USD 631.6 million in 2024.
- The market is expected to grow at a CAGR of 9.5% from 2025 to 2030.
- In terms of segment, viagra (sildenafil citrate) was the largest revenue generating product in 2024.
- Other Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 631.6 million |
| Market revenue in 2030 | USD 1,080.2 million |
| Growth rate | 9.5% (CAGR from 2025 to 2030) |
| Largest segment | Viagra (sildenafil citrate) |
| Fastest growing segment | Other Drugs |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Viagra (sildenafil citrate), Cialis (Tadalafil), Levitra/Staxyn (vardenafil), Stendra/Spedra (avanafil), Other Drugs |
| Key market players worldwide | Pfizer Inc, Eli Lilly and Co, Teva Pharmaceutical Industries Ltd, Sanofi SA, Sun Pharmaceutical Industries, Bayer AG, Petros Pharmaceuticals Inc Ordinary Shares, Cipla Ltd DR, Icahn Enterprises LP Depositary Units Repr Units of LP Interests, Auxilium Pharmaceuticals |
Other key industry trends
- In terms of revenue, Europe region accounted for 21.6% of the global erectile dysfunction drugs market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,033.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Erectile Dysfunction Drugs Market Scope
Erectile Dysfunction Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe erectile dysfunction drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to erectile dysfunction drugs market will help companies and investors design strategic landscapes.
Viagra (sildenafil citrate) was the largest segment with a revenue share of 62.08% in 2024. Horizon Databook has segmented the Europe erectile dysfunction drugs market based on viagra (sildenafil citrate), cialis (tadalafil), levitra/staxyn (vardenafil), stendra/spedra (avanafil), other drugs covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Europe erectile dysfunction drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe erectile dysfunction drugs market databook
-
Our clientele includes a mix of erectile dysfunction drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe erectile dysfunction drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Europe erectile dysfunction drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe erectile dysfunction drugs market size, by country, 2018-2030 (US$M)
Europe Erectile Dysfunction Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
